Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of pancreatic cancer enhances fluorescence-guided surgery

S. Yano; Y. Hiroshima; A. Maawy; H. Kishimoto; A. Suetsugu; S. Miwa; M. Toneri; M. Yamamoto; M. H.G. Katz; J. B. Fleming; Y. Urata; H. Tazawa; S. Kagawa; M. Bouvet; T. Fujiwara; R. M. Hoffman

doi:10.1038/cgt.2015.26

Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of pancreatic cancer enhances fluorescence-guided surgery

S. Yano, Y. Hiroshima, A. Maawy, H. Kishimoto, A. Suetsugu, S. Miwa, M. Toneri, M. Yamamoto, M. H.G. Katz, J. B. Fleming, Y. Urata, H. Tazawa, S. Kagawa, M. Bouvet, T. Fujiwara, R. M. Hoffman

Surgical Oncology

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Abstract

Precise fluorescence-guided surgery (FGS) for pancreatic cancer has the potential to greatly improve the outcome in this recalcitrant disease. To achieve this goal, we have used genetic reporters to color code cancer and stroma cells in a patient-derived orthotopic xenograft (PDOX) model. The telomerase-dependent green fluorescent protein (GFP)-containing adenovirus OBP-401 was used to label the cancer cells of a pancreatic cancer PDOX. The PDOX was previously grown in a red fluorescent protein (RFP) transgenic mouse that stably labeled the PDOX stroma cells bright red. The color-coded PDOX model enabled FGS to completely resect the pancreatic tumors including stroma. Dual-colored FGS significantly prevented local recurrence, which bright-light surgery or single-color FGS could not. FGS, with color-coded cancer and stroma cells has important potential for improving the outcome of recalcitrant-cancer surgery.

Original language	English (US)
Pages (from-to)	344-350
Number of pages	7
Journal	Cancer gene therapy
Volume	22
Issue number	7
DOIs	https://doi.org/10.1038/cgt.2015.26
State	Published - Jul 25 2015

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Cancer Research

Access to Document

10.1038/cgt.2015.26

Cite this

Yano, S., Hiroshima, Y., Maawy, A., Kishimoto, H., Suetsugu, A., Miwa, S., Toneri, M., Yamamoto, M., Katz, M. H. G., Fleming, J. B., Urata, Y., Tazawa, H., Kagawa, S., Bouvet, M., Fujiwara, T., & Hoffman, R. M. (2015). Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of pancreatic cancer enhances fluorescence-guided surgery. Cancer gene therapy, 22(7), 344-350. https://doi.org/10.1038/cgt.2015.26

Yano, S, Hiroshima, Y, Maawy, A, Kishimoto, H, Suetsugu, A, Miwa, S, Toneri, M, Yamamoto, M, Katz, MHG, Fleming, JB, Urata, Y, Tazawa, H, Kagawa, S, Bouvet, M, Fujiwara, T & Hoffman, RM 2015, 'Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of pancreatic cancer enhances fluorescence-guided surgery', Cancer gene therapy, vol. 22, no. 7, pp. 344-350. https://doi.org/10.1038/cgt.2015.26

@article{a0f75248d4ea40938d9a0345b5b77eae,

title = "Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of pancreatic cancer enhances fluorescence-guided surgery",

abstract = "Precise fluorescence-guided surgery (FGS) for pancreatic cancer has the potential to greatly improve the outcome in this recalcitrant disease. To achieve this goal, we have used genetic reporters to color code cancer and stroma cells in a patient-derived orthotopic xenograft (PDOX) model. The telomerase-dependent green fluorescent protein (GFP)-containing adenovirus OBP-401 was used to label the cancer cells of a pancreatic cancer PDOX. The PDOX was previously grown in a red fluorescent protein (RFP) transgenic mouse that stably labeled the PDOX stroma cells bright red. The color-coded PDOX model enabled FGS to completely resect the pancreatic tumors including stroma. Dual-colored FGS significantly prevented local recurrence, which bright-light surgery or single-color FGS could not. FGS, with color-coded cancer and stroma cells has important potential for improving the outcome of recalcitrant-cancer surgery.",

author = "S. Yano and Y. Hiroshima and A. Maawy and H. Kishimoto and A. Suetsugu and S. Miwa and M. Toneri and M. Yamamoto and Katz, {M. H.G.} and Fleming, {J. B.} and Y. Urata and H. Tazawa and S. Kagawa and M. Bouvet and T. Fujiwara and Hoffman, {R. M.}",

year = "2015",

month = jul,

day = "25",

doi = "10.1038/cgt.2015.26",

language = "English (US)",

volume = "22",

pages = "344--350",

journal = "Cancer gene therapy",

issn = "0929-1903",

publisher = "Nature Publishing Group",

number = "7",

}

TY - JOUR

T1 - Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of pancreatic cancer enhances fluorescence-guided surgery

AU - Yano, S.

AU - Hiroshima, Y.

AU - Maawy, A.

AU - Kishimoto, H.

AU - Suetsugu, A.

AU - Miwa, S.

AU - Toneri, M.

AU - Yamamoto, M.

AU - Katz, M. H.G.

AU - Fleming, J. B.

AU - Urata, Y.

AU - Tazawa, H.

AU - Kagawa, S.

AU - Bouvet, M.

AU - Fujiwara, T.

AU - Hoffman, R. M.

PY - 2015/7/25

Y1 - 2015/7/25

N2 - Precise fluorescence-guided surgery (FGS) for pancreatic cancer has the potential to greatly improve the outcome in this recalcitrant disease. To achieve this goal, we have used genetic reporters to color code cancer and stroma cells in a patient-derived orthotopic xenograft (PDOX) model. The telomerase-dependent green fluorescent protein (GFP)-containing adenovirus OBP-401 was used to label the cancer cells of a pancreatic cancer PDOX. The PDOX was previously grown in a red fluorescent protein (RFP) transgenic mouse that stably labeled the PDOX stroma cells bright red. The color-coded PDOX model enabled FGS to completely resect the pancreatic tumors including stroma. Dual-colored FGS significantly prevented local recurrence, which bright-light surgery or single-color FGS could not. FGS, with color-coded cancer and stroma cells has important potential for improving the outcome of recalcitrant-cancer surgery.

AB - Precise fluorescence-guided surgery (FGS) for pancreatic cancer has the potential to greatly improve the outcome in this recalcitrant disease. To achieve this goal, we have used genetic reporters to color code cancer and stroma cells in a patient-derived orthotopic xenograft (PDOX) model. The telomerase-dependent green fluorescent protein (GFP)-containing adenovirus OBP-401 was used to label the cancer cells of a pancreatic cancer PDOX. The PDOX was previously grown in a red fluorescent protein (RFP) transgenic mouse that stably labeled the PDOX stroma cells bright red. The color-coded PDOX model enabled FGS to completely resect the pancreatic tumors including stroma. Dual-colored FGS significantly prevented local recurrence, which bright-light surgery or single-color FGS could not. FGS, with color-coded cancer and stroma cells has important potential for improving the outcome of recalcitrant-cancer surgery.

UR - http://www.scopus.com/inward/record.url?scp=84937978947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937978947&partnerID=8YFLogxK

U2 - 10.1038/cgt.2015.26

DO - 10.1038/cgt.2015.26

M3 - Article

C2 - 26088297

AN - SCOPUS:84937978947

SN - 0929-1903

VL - 22

SP - 344

EP - 350

JO - Cancer gene therapy

JF - Cancer gene therapy

IS - 7

ER -

Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of pancreatic cancer enhances fluorescence-guided surgery

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this